Published in Cell on January 10, 2003
Structural basis of integrin regulation and signaling. Annu Rev Immunol (2007) 8.60
Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature (2004) 5.87
Integrin ligands at a glance. J Cell Sci (2006) 4.76
Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation. Proc Natl Acad Sci U S A (2004) 3.10
Structure of integrin alpha5beta1 in complex with fibronectin. EMBO J (2003) 2.99
Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol (2011) 2.58
Structure and mechanics of integrin-based cell adhesion. Curr Opin Cell Biol (2007) 2.48
Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1. Immunity (2007) 2.43
Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1. Proc Natl Acad Sci U S A (2007) 2.27
Integrins as therapeutic targets: lessons and opportunities. Nat Rev Drug Discov (2010) 2.27
The primacy of affinity over clustering in regulation of adhesiveness of the integrin {alpha}L{beta}2. J Cell Biol (2004) 2.22
Linking integrin conformation to function. J Cell Sci (2009) 2.15
Integrin structures and conformational signaling. Curr Opin Cell Biol (2006) 2.03
Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes. Immunity (2010) 2.00
Rolling cell adhesion. Annu Rev Cell Dev Biol (2010) 1.97
Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor. Proc Natl Acad Sci U S A (2004) 1.91
Integrin inside-out signaling and the immunological synapse. Curr Opin Cell Biol (2011) 1.89
A talin-dependent LFA-1 focal zone is formed by rapidly migrating T lymphocytes. J Cell Biol (2005) 1.88
Importance of force linkage in mechanochemistry of adhesion receptors. Biochemistry (2006) 1.87
Structure of an integrin with an alphaI domain, complement receptor type 4. EMBO J (2009) 1.70
Neutrophil adhesion and activation under flow. Microcirculation (2009) 1.67
Distinct roles for talin-1 and kindlin-3 in LFA-1 extension and affinity regulation. Blood (2012) 1.64
Why integrin as a primary target for imaging and therapy. Theranostics (2011) 1.61
Structures of C3b in complex with factors B and D give insight into complement convertase formation. Science (2010) 1.59
CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function. Proc Natl Acad Sci U S A (2005) 1.51
Intersubunit signal transmission in integrins by a receptor-like interaction with a pull spring. Proc Natl Acad Sci U S A (2004) 1.49
Regulation of integrin affinity on cell surfaces. EMBO J (2011) 1.47
ADAP-SLP-76 binding differentially regulates supramolecular activation cluster (SMAC) formation relative to T cell-APC conjugation. J Exp Med (2004) 1.44
Forcing switch from short- to intermediate- and long-lived states of the alphaA domain generates LFA-1/ICAM-1 catch bonds. J Biol Chem (2010) 1.40
Two-dimensional kinetics regulation of alphaLbeta2-ICAM-1 interaction by conformational changes of the alphaL-inserted domain. J Biol Chem (2005) 1.38
Mechanisms and consequences of neutrophil interaction with the endothelium. Am J Pathol (2007) 1.38
Activation of integrin beta-subunit I-like domains by one-turn C-terminal alpha-helix deletions. Proc Natl Acad Sci U S A (2004) 1.35
Directed evolution to probe protein allostery and integrin I domains of 200,000-fold higher affinity. Proc Natl Acad Sci U S A (2006) 1.32
An atomic resolution view of ICAM recognition in a complex between the binding domains of ICAM-3 and integrin alphaLbeta2. Proc Natl Acad Sci U S A (2005) 1.30
Organization of the integrin LFA-1 in nanoclusters regulates its activity. Mol Biol Cell (2006) 1.26
Rational design of intercellular adhesion molecule-1 (ICAM-1) variants for antagonizing integrin lymphocyte function-associated antigen-1-dependent adhesion. J Biol Chem (2005) 1.24
Exposure of acidic residues as a danger signal for recognition of fibrinogen and other macromolecules by integrin alphaXbeta2. Proc Natl Acad Sci U S A (2005) 1.24
Dynamic shifts in LFA-1 affinity regulate neutrophil rolling, arrest, and transmigration on inflamed endothelium. Blood (2005) 1.22
Vav1 and Rac control chemokine-promoted T lymphocyte adhesion mediated by the integrin alpha4beta1. Mol Biol Cell (2005) 1.21
Biomechanics of leukocyte rolling. Biorheology (2011) 1.20
AL-57, a ligand-mimetic antibody to integrin LFA-1, reveals chemokine-induced affinity up-regulation in lymphocytes. Proc Natl Acad Sci U S A (2006) 1.20
Leukocyte integrins and their ligand interactions. Immunol Res (2009) 1.18
Force spectroscopy of LFA-1 and its ligands, ICAM-1 and ICAM-2. Biomacromolecules (2006) 1.18
Computation of conformational coupling in allosteric proteins. PLoS Comput Biol (2009) 1.16
Integrins alpha1beta1 and alpha2beta1 are receptors for the rotavirus enterotoxin. Proc Natl Acad Sci U S A (2008) 1.15
Distinct roles for LFA-1 affinity regulation during T-cell adhesion, diapedesis, and interstitial migration in lymph nodes. Blood (2009) 1.15
Lateral mobility of individual integrin nanoclusters orchestrates the onset for leukocyte adhesion. Proc Natl Acad Sci U S A (2012) 1.15
Outside-in signal transmission by conformational changes in integrin Mac-1. J Immunol (2009) 1.14
Efalizumab binding to the LFA-1 alphaL I domain blocks ICAM-1 binding via steric hindrance. Proc Natl Acad Sci U S A (2009) 1.13
Small-molecule inhibitors of integrin alpha2beta1 that prevent pathological thrombus formation via an allosteric mechanism. Proc Natl Acad Sci U S A (2009) 1.13
Transition from rolling to firm adhesion can be mimicked by extension of integrin alphaLbeta2 in an intermediate affinity state. J Biol Chem (2006) 1.12
Crystal structure of isoflurane bound to integrin LFA-1 supports a unified mechanism of volatile anesthetic action in the immune and central nervous systems. FASEB J (2009) 1.12
Novel aspects in the regulation of the leukocyte adhesion cascade. Thromb Haemost (2009) 1.11
Neutrophil arrest by LFA-1 activation. Front Immunol (2012) 1.11
Regulation of outside-in signaling and affinity by the beta2 I domain of integrin alphaLbeta2. Proc Natl Acad Sci U S A (2006) 1.10
The cytoplasmic domain of anthrax toxin receptor 1 affects binding of the protective antigen. Infect Immun (2008) 1.09
The power of AAA-ATPases on the road of pre-60S ribosome maturation--molecular machines that strip pre-ribosomal particles. Biochim Biophys Acta (2011) 1.09
Analysis and validation of carbohydrate three-dimensional structures. Acta Crystallogr D Biol Crystallogr (2009) 1.08
Azi-isoflurane, a Photolabel Analog of the Commonly Used Inhaled General Anesthetic Isoflurane. ACS Chem Neurosci (2009) 1.08
Integrin-based therapeutics: biological basis, clinical use and new drugs. Nat Rev Drug Discov (2016) 1.06
The regulation of integrin function by divalent cations. Cell Adh Migr (2012) 1.03
Long-lived, high-strength states of ICAM-1 bonds to beta2 integrin, I: lifetimes of bonds to recombinant alphaLbeta2 under force. Biophys J (2010) 1.01
Supported bilayers at the vanguard of immune cell activation studies. J Struct Biol (2009) 1.01
Integrin activation dynamics between the RGD-binding site and the headpiece hinge. J Biol Chem (2009) 1.01
An unusual allosteric mobility of the C-terminal helix of a high-affinity alphaL integrin I domain variant bound to ICAM-5. Mol Cell (2008) 1.01
Distinct roles of beta1 metal ion-dependent adhesion site (MIDAS), adjacent to MIDAS (ADMIDAS), and ligand-associated metal-binding site (LIMBS) cation-binding sites in ligand recognition by integrin alpha2beta1. J Biol Chem (2008) 1.00
Novel activating and inactivating mutations in the integrin beta1 subunit A domain. Biochem J (2004) 0.99
RKIKK motif in the intracellular domain is critical for spatial and dynamic organization of ICAM-1: functional implication for the leukocyte adhesion and transmigration. Mol Biol Cell (2007) 0.99
Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response. Toxins (Basel) (2011) 0.99
Specific and covalent labeling of a membrane protein with organic fluorochromes and quantum dots. Proc Natl Acad Sci U S A (2007) 0.99
Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1. J Leukoc Biol (2006) 0.98
An internal ligand-bound, metastable state of a leukocyte integrin, αXβ2. J Cell Biol (2013) 0.98
The interaction of Thrombospondins with extracellular matrix proteins. J Cell Commun Signal (2009) 0.97
LFA-1 affinity regulation is necessary for the activation and proliferation of naive T cells. J Biol Chem (2009) 0.97
Multiple lupus-associated ITGAM variants alter Mac-1 functions on neutrophils. Arthritis Rheum (2013) 0.96
Structural plasticity in Ig superfamily domain 4 of ICAM-1 mediates cell surface dimerization. Proc Natl Acad Sci U S A (2007) 0.96
Yeast surface two-hybrid for quantitative in vivo detection of protein-protein interactions via the secretory pathway. J Biol Chem (2009) 0.95
Isoflurane binds and stabilizes a closed conformation of the leukocyte function-associated antigen-1. FASEB J (2012) 0.94
The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding. FASEB J (2009) 0.94
Modular design of immunological synapses and kinapses. Cold Spring Harb Perspect Biol (2009) 0.94
The crystal structure of C2a, the catalytic fragment of classical pathway C3 and C5 convertase of human complement. J Mol Biol (2006) 0.93
Sevoflurane binds and allosterically blocks integrin lymphocyte function-associated antigen-1. Anesthesiology (2010) 0.93
Long-lived, high-strength states of ICAM-1 bonds to beta2 integrin, II: lifetimes of LFA-1 bonds under force in leukocyte signaling. Biophys J (2010) 0.93
F-actin flow drives affinity maturation and spatial organization of LFA-1 at the immunological synapse. J Cell Biol (2015) 0.92
Molecular mechanism of alpha2beta1 integrin interaction with human echovirus 1. EMBO J (2009) 0.92
Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats. Int J Nanomedicine (2012) 0.92
Transmembrane communication: general principles and lessons from the structure and function of the M2 proton channel, K⁺ channels, and integrin receptors. Annu Rev Biochem (2011) 0.92
Structure of the F-spondin domain of mindin, an integrin ligand and pattern recognition molecule. EMBO J (2009) 0.91
Combinatorial libraries against libraries for selecting neoepitope activation-specific antibodies. Proc Natl Acad Sci U S A (2010) 0.91
Action and Traction: Cytoskeletal Control of Receptor Triggering at the Immunological Synapse. Front Immunol (2016) 0.91
Lectin site ligation of CR3 induces conformational changes and signaling. J Biol Chem (2011) 0.91
Slow, reversible, coupled folding and binding of the spectrin tetramerization domain. Biophys J (2012) 0.91
Structural basis of activation-dependent binding of ligand-mimetic antibody AL-57 to integrin LFA-1. Proc Natl Acad Sci U S A (2009) 0.90
Molecular basis for complement recognition by integrin αXβ2. Proc Natl Acad Sci U S A (2012) 0.90
T cell antigen recognition at the cell membrane. Mol Immunol (2012) 0.90
T-cell migration: a naive paradigm? Immunology (2007) 0.90
Competition between intercellular adhesion molecule-1 and a small-molecule antagonist for a common binding site on the alphal subunit of lymphocyte function-associated antigen-1. Protein Sci (2005) 0.89
Targeted molecular dynamics reveals overall common conformational changes upon hybrid domain swing-out in beta3 integrins. Proteins (2009) 0.88
Engineering of single Ig superfamily domain of intercellular adhesion molecule 1 (ICAM-1) for native fold and function. J Biol Chem (2010) 0.88
Structural basis and kinetics of force-induced conformational changes of an αA domain-containing integrin. PLoS One (2011) 0.88
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
SHELXL: high-resolution refinement. Methods Enzymol (1997) 43.04
Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins (1991) 36.69
Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D Biol Crystallogr (1994) 17.44
The immunological synapse: a molecular machine controlling T cell activation. Science (1999) 17.41
Integrin signaling. Science (1999) 16.44
The atomic structure of protein-protein recognition sites. J Mol Biol (1999) 12.63
An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J Mol Graph Model (1997) 11.53
T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature (1989) 9.29
Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell (2002) 7.03
ARP/wARP and molecular replacement. Acta Crystallogr D Biol Crystallogr (2001) 6.03
Structural basis of collagen recognition by integrin alpha2beta1. Cell (2000) 4.84
The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell (1990) 4.83
Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell (1995) 4.73
Networks and crosstalk: integrin signalling spreads. Nat Cell Biol (2002) 4.66
The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol (1990) 4.03
Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct (2001) 3.74
Structure and function of leukocyte integrins. Immunol Rev (1990) 3.62
Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure (1995) 3.15
A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J Cell Biol (1993) 3.14
Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity (2000) 2.96
Integrin affinity modulation. Trends Cell Biol (1998) 2.44
Reversibly locking a protein fold in an active conformation with a disulfide bond: integrin alphaL I domains with high affinity and antagonist activity in vivo. Proc Natl Acad Sci U S A (2001) 2.35
Locking in alternate conformations of the integrin alphaLbeta2 I domain with disulfide bonds reveals functional relationships among integrin domains. Proc Natl Acad Sci U S A (2001) 2.12
Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, alpha L beta 2) integrin. Proc Natl Acad Sci U S A (1995) 2.12
Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J Immunol (1994) 2.11
A dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1. Proc Natl Acad Sci U S A (1998) 1.91
Direct evidence for two affinity states for lymphocyte function-associated antigen 1 on activated T cells. J Biol Chem (1993) 1.88
Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. J Mol Biol (1999) 1.83
Leukocyte adhesion--structure and function of human leukocyte beta2-integrins and their cellular ligands. Eur J Biochem (1997) 1.81
T cell adhesion to intercellular adhesion molecule-1 (ICAM-1) is controlled by cell spreading and the activation of integrin LFA-1. J Immunol (1996) 1.78
NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding. Proc Natl Acad Sci U S A (2000) 1.75
The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand. Proc Natl Acad Sci U S A (1998) 1.73
Crystal structure of the I domain from integrin alpha2beta1. J Biol Chem (1997) 1.69
Does the integrin alphaA domain act as a ligand for its betaA domain? Curr Biol (2002) 1.69
A binding interface on the I domain of lymphocyte function-associated antigen-1 (LFA-1) required for specific interaction with intercellular adhesion molecule 1 (ICAM-1). J Biol Chem (1995) 1.66
Structural specializations of immunoglobulin superfamily members for adhesion to integrins and viruses. Immunol Rev (1998) 1.62
The actin cytoskeleton regulates LFA-1 ligand binding through avidity rather than affinity changes. J Biol Chem (1999) 1.56
Conformational changes in tertiary structure near the ligand binding site of an integrin I domain. Proc Natl Acad Sci U S A (1999) 1.54
The role of the divalent cation in the structure of the I domain from the CD11a/CD18 integrin. Structure (1996) 1.53
Real time analysis of the affinity regulation of alpha 4-integrin. The physiologically activated receptor is intermediate in affinity between resting and Mn(2+) or antibody activation. J Biol Chem (2001) 1.51
Regulation of locomotion and cell-cell contact area by the LFA-1 and ICAM-1 adhesion receptors. J Immunol (1992) 1.48
Cellular activation of leukocyte function-associated antigen-1 and its affinity are regulated at the I domain allosteric site. J Immunol (2001) 1.38
Crystal structure of ICAM-2 reveals a distinctive integrin recognition surface. Nature (1997) 1.34
NMR solution structure of the inserted domain of human leukocyte function associated antigen-1. J Mol Biol (2000) 1.27
Critical threonine and aspartic acid residues within the I domains of beta 2 integrins for interactions with intercellular adhesion molecule 1 (ICAM-1) and C3bi. J Biol Chem (1995) 1.23
Activation-induced conformational changes in the I domain region of lymphocyte function-associated antigen 1. J Biol Chem (2002) 1.14
Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis. J Am Acad Dermatol (2000) 1.11
Mapping the intercellular adhesion molecule-1 and -2 binding site on the inserted domain of leukocyte function-associated antigen-1. J Biol Chem (1998) 1.06
Identification of the binding site in intercellular adhesion molecule 1 for its receptor, leukocyte function-associated antigen 1. Mol Biol Cell (1997) 1.05
Characterization of a conformationally sensitive murine monoclonal antibody directed to the metal ion-dependent adhesion site face of integrin CD11b. J Immunol (2002) 0.94